Epirus Biopharmaceuticals

Epirus Biopharmaceuticals

closed
Expert insights on pharmaceuticals and health supplements to enhance mental and physical well-being. Learn more

Launch date
Employees
Market cap
$15.7k
Enterprise valuation
($6m) (Public information from May 2024)
Massachusetts United States (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO

$8.1m

Post IPO Equity

$5.0m

Post IPO Equity

$36.0m

Post IPO Equity
*
N/A

$44.2m

Post IPO Equity
Total Funding-

Recent News about Epirus Biopharmaceuticals

Edit
More about Epirus Biopharmaceuticalsinfo icon
Edit

Epirus Biopharma is dedicated to providing comprehensive information on pharmaceuticals and health supplements aimed at improving mental and physical health. The company focuses on educating consumers about the benefits and informed use of these products, particularly in relation to thyroid health and its impact on overall well-being. Epirus Biopharma operates in the health and wellness market, targeting individuals seeking to enhance their quality of life through informed health choices. The business model revolves around content creation and dissemination, leveraging the latest research and trends in the health industry to attract and retain a dedicated audience. Revenue is generated through advertising, partnerships, and possibly affiliate marketing with health supplement providers.

Keywords: pharmaceuticals, health supplements, thyroid health, mental well-being, physical well-being, consumer education, health industry, content creation, advertising, partnerships.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Epirus Biopharmaceuticals

Edit
Bioceros
ACQUISITION by Epirus Biopharmaceuticals Sep 2015
Zalicus
ACQUISITION by Epirus Biopharmaceuticals Jul 2014